Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 69,720,984
  • Shares Outstanding, K 384,180
  • Annual Sales, $ 18,471 M
  • Annual Income, $ 12,202 M
  • 60-Month Beta 1.74
  • Price/Sales 3.66
  • Price/Cash Flow 5.71
  • Price/Book 3.89
Trade MRNA with:

Options Overview Details

View History
  • Implied Volatility 60.04% ( -2.69%)
  • Historical Volatility 42.97%
  • IV Percentile 8%
  • IV Rank 12.14%
  • IV High 98.09% on 02/23/22
  • IV Low 54.79% on 08/12/22
  • Put/Call Vol Ratio 0.34
  • Today's Volume 69,900
  • Volume Avg (30-Day) 47,686
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 526,593
  • Open Int (30-Day) 517,857

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 4.77
  • Number of Estimates 9
  • High Estimate 6.13
  • Low Estimate 2.97
  • Prior Year 11.29
  • Growth Rate Est. (year over year) -57.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
135.09 +34.98%
on 11/03/22
188.65 -3.34%
on 11/16/22
+33.73 (+22.70%)
since 11/02/22
3-Month
115.03 +58.52%
on 09/29/22
188.65 -3.34%
on 11/16/22
+43.78 (+31.59%)
since 09/02/22
52-Week
115.03 +58.52%
on 09/29/22
321.30 -43.25%
on 12/20/21
-119.14 (-39.52%)
since 12/02/21

Most Recent Stories

More News
Moderna Stock: Buy, Sell, or Hold in 2023?

Moderna has reached an important turning point.

PFE : 50.91 (-0.33%)
MRNA : 182.35 (+0.48%)
Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL

The WHO updates Emergency Use Listing (EUL) for Novavax's (NVAX) COVID-19 vaccine to include its use as a primary series in adolescents and for use as a booster dose in adults.

PFE : 50.91 (-0.33%)
MRNA : 182.35 (+0.48%)
NVAX : 16.52 (-1.96%)
BNTX : 169.74 (+0.16%)
Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?

Tech layoffs are in the news, but life sciences companies seem to be doing better.

LLY : 374.76 (+1.20%)
BMY : 81.13 (+0.31%)
SAP : 112.03 (+0.02%)
UBER : 28.75 (+1.45%)
MAXR : 25.72 (+3.71%)
TAK : 14.82 (-0.34%)
META : 123.49 (+2.53%)
AMZN : 94.13 (-1.43%)
SNY : 45.01 (-1.87%)
MRNA : 182.35 (+0.48%)
ARE : 153.32 (-1.00%)
SLG : 40.61 (-1.93%)
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023

Pfizer's revenue growth is far from over.

MRK : 110.04 (+0.22%)
ABBV : 163.66 (+1.26%)
MRNA : 182.35 (+0.48%)
PFE : 50.91 (-0.33%)
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why

Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.

PFE : 50.91 (-0.33%)
MRNA : 182.35 (+0.48%)
NVAX : 16.52 (-1.96%)
BNTX : 169.74 (+0.16%)
Is Novavax Stock a Buy Now?

There's probably not much good news coming for this biotech in the near future.

MRNA : 182.35 (+0.48%)
BNTX : 169.74 (+0.16%)
PFE : 50.91 (-0.33%)
NVAX : 16.52 (-1.96%)
The Worst Mistake Moderna Investors Can Make in 2023

Moderna faces a major transition in 2023.

MRNA : 182.35 (+0.48%)
Novavax Stock: Buy, Sell, or Hold in 2023?

The shares are heading for almost a 90% loss this year.

MRNA : 182.35 (+0.48%)
PFE : 50.91 (-0.33%)
NVAX : 16.52 (-1.96%)
Novavax (NVAX) Cancels COVID Jab Supply Deal With GAVI

Novavax (NVAX) claims that GAVI's failure to procure its COVID vaccine doses is a reason to terminate the supply agreement. GAVI denies the company's claims and a legal battle is likely to follow.

PFE : 50.91 (-0.33%)
MRNA : 182.35 (+0.48%)
NVAX : 16.52 (-1.96%)
BNTX : 169.74 (+0.16%)
Buy this Medical Sector Pioneer Stock

Gilead Sciences (GILD) is up roughly 20% since its Q3 release in October, let's take a look at what could continue propelling GILD stock.

GILD : 89.03 (+1.29%)
AMGN : 285.51 (-0.15%)
MRNA : 182.35 (+0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 190.23
2nd Resistance Point 186.52
1st Resistance Point 184.43
Last Price 182.35
1st Support Level 178.63
2nd Support Level 174.92
3rd Support Level 172.83

See More

52-Week High 321.30
Fibonacci 61.8% 242.51
Fibonacci 50% 218.17
Fibonacci 38.2% 193.83
Last Price 182.35
52-Week Low 115.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar